Works matching IS 08876924 AND DT 2014 AND VI 28 AND IP 5

Results: 39

miR-9 is a tumor suppressor in pediatric AML with t(8;21).

Published in:

2014

By:

Emmrich, S;
Katsman-Kuipers, J E;
Henke, K;
Khatib, M E;
Jammal, R;
Engeland, F;
Dasci, F;
Zwaan, C M;
den Boer, M L;
Verboon, L;
Stary, J;
Baruchel, A;
de Haas, V;
Danen-van Oorschot, A A;
Fornerod, M;
Pieters, R;
Reinhardt, D;
Klusmann, J H;
van den Heuvel-Eibrink, M M

Publication type:

journal article

Enhancers of Polycomb EPC1 and EPC2 sustain the oncogenic potential of MLL leukemia stem cells.

Published in:

Leukemia (08876924), 2014, v. 28, n. 5, p. 1081, doi. 10.1038/leu.2013.316

By:

Huang, X;
Spencer, G J;
Lynch, J T;
Ciceri, F;
Somerville, T D D;
Somervaille, T C P

Publication type:

Article

International Myeloma Working Group recommendations for global myeloma care.

Published in:

2014

By:

Ludwig, H;
Miguel, J S;
Dimopoulos, M A;
Palumbo, A;
Garcia Sanz, R;
Powles, R;
Lentzsch, S;
Ming Chen, W;
Hou, J;
Jurczyszyn, A;
Romeril, K;
Hajek, R;
Terpos, E;
Shimizu, K;
Joshua, D;
Hungria, V;
Rodriguez Morales, A;
Ben-Yehuda, D;
Sondergeld, P;
Zamagni, E

Publication type:

journal article

Extended survival and reduced risk of AML progression in erythroid-responsive lenalidomide-treated patients with lower-risk del(5q) MDS.

Published in:

2014

By:

List, A F;
Bennett, J M;
Sekeres, M A;
Skikne, B;
Fu, T;
Shammo, J M;
Nimer, S D;
Knight, R D;
Giagounidis, A;
MDS-003 Study Investigators

Publication type:

journal article

Progressive changes in chromatin structure and DNA damage response signals in bone marrow and peripheral blood during myelomagenesis.

Published in:

2014

By:

Gkotzamanidou, M;
Terpos, E;
Bamia, C;
Kyrtopoulos, S A;
Sfikakis, P P;
Dimopoulos, M A;
Souliotis, V L

Publication type:

journal article

Functional impact of NOTCH1 mutations in chronic lymphocytic leukemia.

Published in:

Leukemia (08876924), 2014, v. 28, n. 5, p. 1060, doi. 10.1038/leu.2013.319

By:

Arruga, F;
Gizdic, B;
Serra, S;
Vaisitti, T;
Ciardullo, C;
Coscia, M;
Laurenti, L;
D'Arena, G;
Jaksic, O;
Inghirami, G;
Rossi, D;
Gaidano, G;
Deaglio, S

Publication type:

Article

miR-9 is a tumor suppressor in pediatric AML with t(8;21).

Published in:

Leukemia (08876924), 2014, v. 28, n. 5, p. 1022, doi. 10.1038/leu.2013.357

By:

Emmrich, S;
Katsman-Kuipers, J E;
Henke, K;
Khatib, M E;
Jammal, R;
Engeland, F;
Dasci, F;
Zwaan, C M;
den Boer, M L;
Verboon, L;
Stary, J;
Baruchel, A;
de Haas, V;
Danen-van Oorschot, A A;
Fornerod, M;
Pieters, R;
Reinhardt, D;
Klusmann, J H;
van den Heuvel-Eibrink, M M

Publication type:

Article

Coinhibitory molecule PD-1 as a potential target for the immunotherapy of multiple myeloma.

Published in:

2014

By:

Atanackovic, D;
Luetkens, T;
Kröger, N

Publication type:

journal article

What does MRD in leukemia really mean?

Published in:

Leukemia (08876924), 2014, v. 28, n. 5, p. 1131, doi. 10.1038/leu.2013.318

By:

Goldman, J M;
Gale, R P

Publication type:

Article

Core-binding factor acute myeloid leukemia in pediatric patients enrolled in the AIEOP AML 2002/01 trial: screening and prognostic impact of c-KIT mutations.

Published in:

Leukemia (08876924), 2014, v. 28, n. 5, p. 1132, doi. 10.1038/leu.2013.339

By:

Manara, E;
Bisio, V;
Masetti, R;
Beqiri, V;
Rondelli, R;
Menna, G;
Micalizzi, C;
Santoro, N;
Locatelli, F;
Basso, G;
Pigazzi, M

Publication type:

Article

Targeted cancer exome sequencing reveals recurrent mutations in myeloproliferative neoplasms.

Published in:

Leukemia (08876924), 2014, v. 28, n. 5, p. 1052, doi. 10.1038/leu.2013.302

By:

Tenedini, E;
Bernardis, I;
Artusi, V;
Artuso, L;
Roncaglia, E;
Guglielmelli, P;
Pieri, L;
Bogani, C;
Biamonte, F;
Rotunno, G;
Mannarelli, C;
Bianchi, E;
Pancrazzi, A;
Fanelli, T;
Malagoli Tagliazucchi, G;
Ferrari, S;
Manfredini, R;
Vannucchi, A M;
Tagliafico, E

Publication type:

Article

Absence of mutations in cereblon (CRBN) and DNA damage-binding protein 1 (DDB1) genes and significance for IMiD therapy.

Published in:

Leukemia (08876924), 2014, v. 28, n. 5, p. 1129, doi. 10.1038/leu.2013.315

By:

Thakurta, A;
Gandhi, A K;
Waldman, M F;
Bjorklund, C;
Ning, Y;
Mendy, D;
Schafer, P;
Lopez-Girona, A;
Lentzsch, S;
Schey, S A;
Calle, Y;
Chelliah, R;
Orlowski, R Z;
Madan, A;
Avet-Loiseau, H;
Chopra, R

Publication type:

Article

Continued improvement in survival in multiple myeloma: changes in early mortality and outcomes in older patients.

Published in:

Leukemia (08876924), 2014, v. 28, n. 5, p. 1122, doi. 10.1038/leu.2013.313

By:

Kumar, S K;
Dispenzieri, A;
Lacy, M Q;
Gertz, M A;
Buadi, F K;
Pandey, S;
Kapoor, P;
Dingli, D;
Hayman, S R;
Leung, N;
Lust, J;
McCurdy, A;
Russell, S J;
Zeldenrust, S R;
Kyle, R A;
Rajkumar, S V

Publication type:

Article

Chemomodulation of sequential high-dose cytarabine by fludarabine in relapsed or refractory acute myeloid leukemia: a randomized trial of the AMLCG.

Published in:

Leukemia (08876924), 2014, v. 28, n. 5, p. 1001, doi. 10.1038/leu.2013.297

By:

Fiegl, M;
Unterhalt, M;
Kern, W;
Braess, J;
Spiekermann, K;
Staib, P;
Grüneisen, A;
Wörmann, B;
Schöndube, D;
Serve, H;
Reichle, A;
Hentrich, M;
Schiel, X;
Sauerland, C;
Heinecke, A;
Rieger, C;
Beelen, D;
Berdel, W E;
Büchner, T;
Hiddemann, W

Publication type:

Article

Tumor suppressor functions of Dnmt3a and Dnmt3b in the prevention of malignant mouse lymphopoiesis.

Published in:

Leukemia (08876924), 2014, v. 28, n. 5, p. 1138, doi. 10.1038/leu.2013.364

By:

Peters, S L;
Hlady, R A;
Opavska, J;
Klinkebiel, D;
Pirruccello, S J;
Talmon, G A;
Sharp, J G;
Wu, L;
Jaenisch, R;
Simpson, M A;
Karpf, A R;
Opavsky, R

Publication type:

Article

Calreticulin gene exon 9 frameshift mutations in patients with thrombocytosis.

Published in:

Leukemia (08876924), 2014, v. 28, n. 5, p. 1152, doi. 10.1038/leu.2013.382

By:

Chi, J;
Nicolaou, K A;
Nicolaidou, V;
Koumas, L;
Mitsidou, A;
Pierides, C;
Manoloukos, M;
Barbouti, K;
Melanthiou, F;
Prokopiou, C;
Vassiliou, G S;
Costeas, P

Publication type:

Article

B-cell receptor pathway inhibitors affect CD20 levels and impair antitumor activity of anti-CD20 monoclonal antibodies.

Published in:

Leukemia (08876924), 2014, v. 28, n. 5, p. 1163, doi. 10.1038/leu.2014.12

By:

Bojarczuk, K;
Siernicka, M;
Dwojak, M;
Bobrowicz, M;
Pyrzynska, B;
Gaj, P;
Karp, M;
Giannopoulos, K;
Efremov, D G;
Fauriat, C;
Golab, J;
Winiarska, M

Publication type:

Article

Coinhibitory molecule PD-1 as a potential target for the immunotherapy of multiple myeloma.

Published in:

Leukemia (08876924), 2014, v. 28, n. 5, p. 993, doi. 10.1038/leu.2013.310

By:

Atanackovic, D;
Luetkens, T;
Kröger, N

Publication type:

Article

ALDH1 activity identifies tumor-initiating cells and links to chromosomal instability signatures in multiple myeloma.

Published in:

Leukemia (08876924), 2014, v. 28, n. 5, p. 1155, doi. 10.1038/leu.2013.383

By:

Zhou, W;
Yang, Y;
Gu, Z;
Wang, H;
Xia, J;
Wu, X;
Zhan, X;
Levasseur, D;
Zhou, Y;
Janz, S;
Tricot, G;
Shi, J;
Zhan, F

Publication type:

Article

A gene expression signature for high-risk multiple myeloma.

Published in:

Leukemia (08876924), 2014, v. 28, n. 5, p. 1178, doi. 10.1038/leu.2014.53

By:

Kuiper, R;
Broyl, A;
de Knegt, Y;
van Vliet, M H;
van Beers, E H;
van der Holt, B;
el Jarari, L;
Mulligan, G;
Gregory, W;
Morgan, G;
Goldschmidt, H;
Lokhorst, H M;
van Duin, M;
Sonneveld, P

Publication type:

Article

Alternatively spliced, truncated GCSF receptor promotes leukemogenic properties and sensitivity to JAK inhibition.

Published in:

Leukemia (08876924), 2014, v. 28, n. 5, p. 1041, doi. 10.1038/leu.2013.321

By:

Mehta, H M;
Futami, M;
Glaubach, T;
Lee, D W;
Andolina, J R;
Yang, Q;
Whichard, Z;
Quinn, M;
Lu, H F;
Kao, W M;
Przychodzen, B;
Sarkar, C A;
Minella, A;
Maciejewski, J P;
Corey, S J

Publication type:

Article

Selinexor suppresses downstream effectors of B-cell activation, proliferation and migration in chronic lymphocytic leukemia cells.

Published in:

Leukemia (08876924), 2014, v. 28, n. 5, p. 1158, doi. 10.1038/leu.2014.9

By:

Zhong, Y;
El-Gamal, D;
Dubovsky, J A;
Beckwith, K A;
Harrington, B K;
Williams, K E;
Goettl, V M;
Jha, S;
Mo, X;
Jones, J A;
Flynn, J M;
Maddocks, K J;
Andritsos, L A;
McCauley, D;
Shacham, S;
Kauffman, M;
Byrd, J C;
Lapalombella, R

Publication type:

Article

BCL2-specific inhibitor ABT-199 synergizes strongly with cytarabine against the early immature LOUCY cell line but not more-differentiated T-ALL cell lines.

Published in:

Leukemia (08876924), 2014, v. 28, n. 5, p. 1145, doi. 10.1038/leu.2013.377

By:

Anderson, N M;
Harrold, I;
Mansour, M R;
Sanda, T;
McKeown, M;
Nagykary, N;
Bradner, J E;
Lan Zhang, G;
Look, A T;
Feng, H

Publication type:

Article

An international study of intrachromosomal amplification of chromosome 21 (iAMP21): cytogenetic characterization and outcome.

Published in:

Leukemia (08876924), 2014, v. 28, n. 5, p. 1015, doi. 10.1038/leu.2013.317

By:

Harrison, C J;
Moorman, A V;
Schwab, C;
Carroll, A J;
Raetz, E A;
Devidas, M;
Strehl, S;
Nebral, K;
Harbott, J;
Teigler-Schlegel, A;
Zimmerman, M;
Dastuge, N;
Baruchel, A;
Soulier, J;
Auclerc, M-F;
Attarbaschi, A;
Mann, G;
Stark, B;
Cazzaniga, G;
Chilton, L

Publication type:

Article

Cyclophosphamide as a first-line therapy in LGL leukemia.

Published in:

Leukemia (08876924), 2014, v. 28, n. 5, p. 1134, doi. 10.1038/leu.2013.359

By:

Moignet, A;
Hasanali, Z;
Zambello, R;
Pavan, L;
Bareau, B;
Tournilhac, O;
Roussel, M;
Fest, T;
Awwad, A;
Baab, K;
Semenzato, G;
Houot, R;
Loughran, T P;
Lamy, T

Publication type:

Article

Expression of putative targets of immunotherapy in acute myeloid leukemia and healthy tissues.

Published in:

Leukemia (08876924), 2014, v. 28, n. 5, p. 1167, doi. 10.1038/leu.2014.14

By:

Goswami, M;
Hensel, N;
Smith, B D;
Prince, G T;
Qin, L;
Levitsky, H I;
Strickland, S A;
Jagasia, M;
Savani, B N;
Fraser, J W;
Sadrzadeh, H;
Rajkhowa, T;
Ito, S;
Jain, N A;
Battiwalla, M;
Fathi, A T;
Levis, M J;
Barrett, A J;
Hourigan, C S

Publication type:

Article

Inherited susceptibility to pre B-ALL caused by germline transmission of PAX5 c.547G>A.

Published in:

Leukemia (08876924), 2014, v. 28, n. 5, p. 1136, doi. 10.1038/leu.2013.363

By:

Auer, F;
Rüschendorf, F;
Gombert, M;
Husemann, P;
Ginzel, S;
Izraeli, S;
Harit, M;
Weintraub, M;
Weinstein, O Y;
Lerer, I;
Stepensky, P;
Borkhardt, A;
Hauer, J

Publication type:

Article

International Myeloma Working Group recommendations for global myeloma care.

Published in:

Leukemia (08876924), 2014, v. 28, n. 5, p. 981, doi. 10.1038/leu.2013.293

By:

Ludwig, H;
Miguel, J S;
Dimopoulos, M A;
Palumbo, A;
Garcia Sanz, R;
Powles, R;
Lentzsch, S;
Ming Chen, W;
Hou, J;
Jurczyszyn, A;
Romeril, K;
Hajek, R;
Terpos, E;
Shimizu, K;
Joshua, D;
Hungria, V;
Rodriguez Morales, A;
Ben-Yehuda, D;
Sondergeld, P;
Zamagni, E

Publication type:

Article

Extended survival and reduced risk of AML progression in erythroid-responsive lenalidomide-treated patients with lower-risk del(5q) MDS.

Published in:

Leukemia (08876924), 2014, v. 28, n. 5, p. 1033, doi. 10.1038/leu.2013.305

By:

List, A F;
Bennett, J M;
Sekeres, M A;
Skikne, B;
Fu, T;
Shammo, J M;
Nimer, S D;
Knight, R D;
Giagounidis, A

Publication type:

Article

Altered expression of miR-24, miR-126 and miR-365 does not affect viability of childhood TCF3-rearranged leukemia cells.

Published in:

Leukemia (08876924), 2014, v. 28, n. 5, p. 1008, doi. 10.1038/leu.2013.308

By:

Akbari Moqadam, F;
Boer, J M;
Lange-Turenhout, E A M;
Pieters, R;
den Boer, M L

Publication type:

Article

Increasing genomic and epigenomic complexity in the clonal evolution from in situ to manifest t(14;18)-positive follicular lymphoma.

Published in:

Leukemia (08876924), 2014, v. 28, n. 5, p. 1103, doi. 10.1038/leu.2013.307

By:

Schmidt, J;
Salaverria, I;
Haake, A;
Bonzheim, I;
Adam, P;
Montes-Moreno, S;
Piris, M A;
Fend, F;
Siebert, R;
Quintanilla-Martinez, L

Publication type:

Article

Whole-exome sequencing in del(5q) myelodysplastic syndromes in transformation to acute myeloid leukemia.

Published in:

Leukemia (08876924), 2014, v. 28, n. 5, p. 1148, doi. 10.1038/leu.2013.381

By:

Pellagatti, A;
Fernandez-Mercado, M;
Di Genua, C;
Larrayoz, M J;
Killick, S;
Dolatshad, H;
Burns, A;
Calasanz, M J;
Schuh, A;
Boultwood, J

Publication type:

Article

Progressive changes in chromatin structure and DNA damage response signals in bone marrow and peripheral blood during myelomagenesis.

Published in:

Leukemia (08876924), 2014, v. 28, n. 5, p. 1113, doi. 10.1038/leu.2013.284

By:

Gkotzamanidou, M;
Terpos, E;
Bamia, C;
Kyrtopoulos, S A;
Sfikakis, P P;
Dimopoulos, M A;
Souliotis, V L

Publication type:

Article

A role for eukaryotic initiation factor 4B overexpression in the pathogenesis of diffuse large B-cell lymphoma.

Published in:

Leukemia (08876924), 2014, v. 28, n. 5, p. 1092, doi. 10.1038/leu.2013.295

By:

Horvilleur, E;
Sbarrato, T;
Hill, K;
Spriggs, R V;
Screen, M;
Goodrem, P J;
Sawicka, K;
Chaplin, L C;
Touriol, C;
Packham, G;
Potter, K N;
Dirnhofer, S;
Tzankov, A;
Dyer, M J S;
Bushell, M;
MacFarlane, M;
Willis, A E

Publication type:

Article

Professor John M Goldman, 1938-2013: Gentleman and Scholar.

Published in:

Leukemia (08876924), 2014, v. 28, n. 5, p. 1175, doi. 10.1038/leu.2014.36

By:

Gale, R P

Publication type:

Article

An MDS xenograft model utilizing a patient-derived cell line.

Published in:

Leukemia (08876924), 2014, v. 28, n. 5, p. 1142, doi. 10.1038/leu.2013.372

By:

Rhyasen, G W;
Wunderlich, M;
Tohyama, K;
Garcia-Manero, G;
Mulloy, J C;
Starczynowski, D T

Publication type:

Article

WTAP is a novel oncogenic protein in acute myeloid leukemia.

Published in:

Leukemia (08876924), 2014, v. 28, n. 5, p. 1171, doi. 10.1038/leu.2014.16

By:

Bansal, H;
Yihua, Q;
Iyer, S P;
Ganapathy, S;
Proia, D;
Penalva, L O;
Uren, P J;
Suresh, U;
Carew, J S;
Karnad, A B;
Weitman, S;
Tomlinson, G E;
Rao, M K;
Kornblau, S M;
Bansal, S

Publication type:

Article

Reprogramming of MLL-AF9 leukemia cells into pluripotent stem cells.

Published in:

Leukemia (08876924), 2014, v. 28, n. 5, p. 1071, doi. 10.1038/leu.2013.304

By:

Liu, Y;
Cheng, H;
Gao, S;
Lu, X;
He, F;
Hu, L;
Hou, D;
Zou, Z;
Li, Y;
Zhang, H;
Xu, J;
Kang, L;
Wang, Q;
Yuan, W;
Cheng, T

Publication type:

Article

Geoffrey Peter Herzig, MD Leukemia Pioneer (1941-2013).

Published in:

Leukemia (08876924), 2014, v. 28, n. 5, p. 1177, doi. 10.1038/leu.2014.43

By:

Gale, R P;
Bloomfield, C D

Publication type:

Article